Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit S7 (NDUFS7) (NDUFS7)

Target
NDUFS7
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial respiratory chain complex
01

Overview

Mitochondrial Complex I, specifically the PSST subunit-associated site, is a critical component of the mitochondrial electron transport chain responsible for the oxidation of NADH and the reduction of ubiquinone (UniProt: P48764). The PSST subunit (NDUFS7) is a core, highly conserved protein that contributes to the formation of the ubiquinone-binding pocket (Q-site) and houses the N2 iron-sulfur cluster, the final electron donor in the complex's electron transfer chain (PubMed: 15544951). In the context of viable cardiomyocytes, this site is a key target for pharmacological intervention to mitigate ischemia-reperfusion injury by reducing the burst of reactive oxygen species (ROS) upon reperfusion (PubMed: 22303013). Drugs like metformin are thought to interact with this region to mildly and reversibly inhibit complex I activity, which provides cardioprotective effects and activates the AMPK pathway (PubMed: 24509906). Beyond cardioprotection, the PSST subunit is clinically significant as mutations in the NDUFS7 gene are a known cause of Leigh syndrome, a severe neurodegenerative disorder characterized by mitochondrial dysfunction (PubMed: 11431143). This site is also the target of classic inhibitors such as rotenone and piericidin A, which are used extensively in biochemical research to study mitochondrial respiration.

Other names
PSST subunitMitochondrial complex I PSST subunitNADH dehydrogenase [ubiquinone] iron-sulfur protein 7CI-PSSTComplex I-7 (CI-7)
02

Mechanism of action

Reversible inhibition of the ubiquinone-binding site (Q-site) of Mitochondrial Complex I, which prevents the transfer of electrons from the N2 iron-sulfur cluster to ubiquinone, thereby modulating the proton motive force and reducing the production of reactive oxygen species.

03

Biological functions

Electron transport chainATP synthesisReactive oxygen species (ROS) productionRedox signalingProton translocation
04

Disease associations

Ischemia-reperfusion injuryLeigh syndromeType 2 diabetesCardiovascular diseaseMitochondrial encephalomyopathy
05

Safety considerations

Lactic acidosisMitochondrial toxicityInhibition of aerobic respirationPotential for cardiac dysfunction if over-inhibitedOptic neuropathy
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Lactate/pyruvate ratioMitochondrial membrane potentialSuperoxide production levelsNDUFS7 mutation statusAMP/ATP ratio

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit S7 (NDUFS7) (NDUFS7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit S7 (NDUFS7) (NDUFS7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call